STOCK TITAN

Plandai Biotechnology, Inc. Announces Rescission of Material Definitive Agreement with Good Salt, LLC

Rhea-AI Impact
(High)
Rhea-AI Sentiment
(Positive)
Tags
Rhea-AI Summary
Plandai Biotechnology, Inc. announces the rescission of a material definitive agreement with Good Salt, LLC due to the failure of consideration. The agreement, initially entered into on May 16, 2023, outlined the terms for the acquisition of the Company. Plandai will evaluate its options moving forward and exploring alternative opportunities for growth and expansion.
Positive
  • Rescission of the agreement presents an opportunity for Plandai to explore alternative growth and expansion options.
Negative
  • The failure of consideration in the agreement is disappointing for Plandai.

SAN DIEGO, CA / ACCESSWIRE / August 1, 2023 / Plandai Biotechnology, Inc. ("Plandai" or the "Company") (OTC:PLPL) announces today the rescission of a material definitive agreement with Good Salt, LLC due to the material failure of consideration in the transaction.

The material definitive agreement, which was initially entered into on May 16, 2023, outlined the terms and conditions for the acquisition of the Company by Good Salt. However, despite diligent efforts and ongoing communications, conditions subsequent to the closing were unmet, and essential considerations were not settled.

As a result, Plandai had no choice but to initiate the rescission process. The rescission will render the material definitive agreement null and void, and both parties will revert to their pre-agreement status.

Plandai's CEO, Tad Mailander, expressed regret about the situation, stating, "It is disappointing that we had to resort to the rescission of the material definitive agreement due to the failure of consideration. We had high hopes for a successful transaction."

The Company's decision to rescind the agreement was approved by both a majority of the Plandai shareholders eligible to vote and the board of directors.

In light of this development, Plandai will evaluate its options moving forward and exploring alternative opportunities for growth and expansion.

Contact

plandai@protonmail.com

SOURCE: Plandai Biotechnology



View source version on accesswire.com:
https://www.accesswire.com/771606/Plandai-Biotechnology-Inc-Announces-Rescission-of-Material-Definitive-Agreement-with-Good-Salt-LLC

FAQ

What is the news about?

The news is about Plandai Biotechnology, Inc. rescinding a material definitive agreement with Good Salt, LLC due to the failure of consideration.

When was the agreement initially entered into?

The agreement was initially entered into on May 16, 2023.

What will Plandai do now?

Plandai will evaluate its options moving forward and explore alternative opportunities for growth and expansion.

PLANDAI BIOTECHNOLOGY INC

OTC:PLPL

PLPL Rankings

PLPL Latest News

PLPL Stock Data

236.87k
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
London

About PLPL

plandaã­ biotechnology, inc. focuses on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries. it is developing phytofare catechin complex, a botanical extract derived from green tea harvested in the senteeko tea estate in mpumalanga, south africa; and phytofare citrus complex, a citrus extract, as well as extracts from tomato fruit, artemisia, and cannabis. the company also produces and sells timber and agricultural products from its farm and tea estate holdings in south africa. plandaã­ biotechnology, inc. is based in london, the united kingdom.